CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed,...
UK NICE has released new guidance for the diagnosis and treatment of prostate cancer, states the BMJ . The recommendations are based on systemic reviews of the best available evidence, supplemented with the guideline development group's opinion of best practice where needed. The guidance covers ...
Dr Matt Hobbs, Deputy Director of Research at Prostate Cancer UK, said: "Forty per cent of men in their 50s, and 75 per cent of men in their 70s, experience uncomfortable urinary symptoms caused by BPH, and treatment options are limited. " This kind of work, that aims to look in deta...
For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα. The findings, published recently inScience Advances, could help address the growing threat of treatment resistance in prostate cancer and could also lead to improved t...
Professor Charles Swanton, Cancer Research UK’s chief clinician, said: “Adding radiotherapy to current treatment shows clear benefit for this subgroup of men with prostate cancer. “We now need to investigate whether this could also work for other types of cancer. If we can understand exactly ...
Welcome to Prostate Cancer 911, your trusted center for comprehensive prostate cancer surgery and treatment in New York.
In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an unde...
In addition, cancer survivors may have treatment-related health problems ranging from the trivial to the very complex, some of *Correspondence: H McConnell; E-mail: hmcconnell@macmillan.org.uk which are amenable to intervention through secondary prevention or detection and effective management. ...
It has worked very well for tumors of the spinal cord. When it comes to prostate cancer, though, there is far less data available. Indeed, there is less data than the amount of information that was available to me at the time I chose my radiation treatment. Expectations are that, because...
A minimally-invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting